TY - JOUR
KW - Cytokines
KW - Humans
KW - leprosy
KW - Mycobacterium Infections
KW - Mycobacterium avium-intracellulare Infection
KW - Recombinant Proteins
KW - Tuberculosis
AU - Bermudez L E
AU - Kaplan G
AB - <p>Knowing how mycobacteria exploit host cytokines to survive and which cytokines have important roles in host defense against mycobacteria should allow the use of these molecules in the treatment of mycobacterial infections. Both interleukin 2 and interferon gamma have been used to treat patients with leprosy, and granulocyte-macrophage colony-stimulating factor is presently being administered to AIDS patients infected with Mycobacterium avium.</p>
BT - Trends in microbiology
C1 - http://www.ncbi.nlm.nih.gov/pubmed/7719635?dopt=Abstract
DA - 1995 Jan
DO - 10.1016/s0966-842x(00)88864-2
IS - 1
J2 - Trends Microbiol.
LA - eng
N2 - <p>Knowing how mycobacteria exploit host cytokines to survive and which cytokines have important roles in host defense against mycobacteria should allow the use of these molecules in the treatment of mycobacterial infections. Both interleukin 2 and interferon gamma have been used to treat patients with leprosy, and granulocyte-macrophage colony-stimulating factor is presently being administered to AIDS patients infected with Mycobacterium avium.</p>
PY - 1995
SP - 22
EP - 7
T2 - Trends in microbiology
TI - Recombinant cytokines for controlling mycobacterial infections.
VL - 3
SN - 0966-842X
ER -